SEC Insider Transactions from MARTELL RON.

Last updated: 2026-03-14 11:43 UTC | Total transactions: 8

Ron Martell, President and CEO of Jasper Therapeutics, Inc. ($JSPR), made two open market purchases of common shares totaling nearly $100,000 in the last 365 days, with the most recent on September 22, 2025. These buys rank 2340th among nearly 5,000 insiders in our database by purchase value, below the average of $1.5 million across 3.3 transactions. Martell had no open market sales during this period.

Set Up your own filters →
Transaction Date Company Ticker Insider Name Title Transaction Type Security Shares Price Shares Owned Following Total Shares Outstanding % of Owned % of Outstanding
Jan. 2, 2026 Jasper Therapeutics, Inc. $JSPR MARTELL RON President, CEO and Director A Stock Option (right to buy) 234000 $0.00 234,000.0000 16,635,784 9999.99% 1.41%
Sept. 22, 2025 Jasper Therapeutics, Inc. $JSPR MARTELL RON President and CEO P Voting Common Stock 41000 $2.43 74,118.0000 15,333,962 123.80% 0.27%
Sept. 22, 2025 Jasper Therapeutics, Inc. $JSPR MARTELL RON President and CEO P Common Stock Warrant (right to buy) 41000 $0.00 41,000.0000 15,333,962 9999.99% 0.27%
June 4, 2025 Jasper Therapeutics, Inc. $JSPR MARTELL RON President and CEO A Stock Option (right to buy) 234000 $0.00 234,000.0000 15,022,122 9999.99% 1.56%
Feb. 13, 2025 Jasper Therapeutics, Inc. $JSPR MARTELL RON President, CEO and Director A Stock Option (right to buy) 130000 $0.00 130,000.0000 14,584,870 9999.99% 0.89%
June 10, 2024 Jasper Therapeutics, Inc. $JSPR MARTELL RON President, CEO and Director A Performance Restricted Stock Units 20000 $0.00 20,000.0000 13,334,900 9999.99% 0.15%
June 10, 2024 Jasper Therapeutics, Inc. $JSPR MARTELL RON President, CEO and Director A Stock Option (right to buy) 10000 $0.00 10,000.0000 13,334,900 9999.99% 0.07%
Feb. 15, 2024 Jasper Therapeutics, Inc. $JSPR MARTELL RON President, CEO and Director A Stock Option (right to buy) 100000 $0.00 100,000.0000 10,439,034 9999.99% 0.96%